AGOURA HILLS, Calif.--(BUSINESS WIRE)--Caldera Medical, a leader in the development of implants for the treatment of female Stress Urinary Incontinence, will attend the Society of Urodynamics, Female Pelvic Medicine & Urogenital Reconstruction Conference in Scottsdale, AZ. Stress Urinary Incontinence, the most prevalent form of incontinence among women, affects an estimated 15 million adult women in the U.S., and incontinence is the second leading cause of institutionalization in older women.
Caldera Medical’s Desara® Family of products for female Stress Urinary Incontinence offers surgeons outstanding flexibility and ease of use. Desara® is the only universal sling system available and provides surgeons with their choice of multiple surgical approaches with the same implant by utilizing reusable instrumentation. This provides surgeons with unparalleled flexibility, helps facilities reduce inventory carrying costs by 75% or more*, while also reducing waste by 94% when compared to other products*. Desara® Blue is a blue version of Caldera Medical’s Desara® universal sling system and provides exceptional visibility both during and after the procedure.
Desara® SL utilizes the same proven Desara® material in a shorter 12 cm length to minimize the amount of mesh implanted. A shorter 12 cm sling length has been shown to significantly reduce post-operative groin pain, making patients more comfortable, while delivering equivalent safety and efficacy as traditional mid-urethral slings*.
“We enjoy coming to SUFU as it is an opportunity for us to highlight our broad portfolio of innovative solutions for the treatment of SUI, one of the primary conditions treated by Urologists and Urogynecologists,” commented Bryon L. Merade, Caldera Medical’s CEO.
Caldera Medical’s other product lines include Vertessa® Lite, a supple, lightweight yet strong polypropylene mesh for use in abdominal sacrocolpopexy procedures for the treatment of Pelvic Organ Prolapse (POP). Pelvic Organ Prolapse (POP) is one of the most common quality of life conditions facing women, with nearly 50% of all women who give birth vaginally developing POP. A woman’s lifetime probability for undergoing a surgical treatment to correct POP is approximately 11%.
About Caldera Medical
Caldera Medical is dedicated to improving quality of life for women. Caldera Medical develops and markets differentiated surgical implants specifically for the treatment of Stress Urinary Incontinence and Pelvic Organ Prolapse across the gynecology, urology and urogynecology specialties.
Caldera Medical is a privately held company located in Agoura Hills, California. For more information, visit Caldera Medical's Web site at www.calderamedical.com.
* Data on file at Caldera Medical.